I thought it was suspicious how they pushed the EU oral question and decision to Sept. when they could have done it in June and made headlines, but they know Qnexa won't gain EU approval because of the banned ingredient. Now, if Qnexa was getting EU approval in two months, wouldn' the Executive hold onto their share to gain in the next "leg up"??? Obviously, there isn't going to be any leg up in VVUS stock price because EU approval isn't happening and there will be a price dump. Very suspicious how executive dumped at $30 - how did they know VVUS would top out at that price when everyone was tooting for over $40 upon approval. The whole VVUS thing is a set-up and orchestrated by the Executive team. CEO and President probably post on the VVUS message board and are the big pumpers over there - notice how much info some of them have - like "inside information" - - -????? makes you think . . .. . People are catching onto this scam!